Advocates, Patient Organizations, Advocacy, Regulatory, Telehealth, Understanding Rare Disease, PDF, Publication, Education, October 17, 2022 NORD RareInsights® Ensuring Access to Telehealth for Rare Diseases
Advocates, Patient Organizations, Researchers, Advocacy, Research & Drug Development, PDF, Publication, Education, Policy, Orphan Drugs in the United States: Rare Disease Innovation and Cost Trends Through 2019
Advocates, Patient Organizations, Researchers, Advocacy, Regulatory, Research & Drug Development, PDF, Publication, Education, Policy, Orphan Drugs in the United States: An Examination of Patents and Orphan Drug Exclusivity
Advocates, Medical Professionals, Researchers, Regulatory, Research & Drug Development, PDF, Publication, Education, FDA’S Accelerated Approval Pathway: A Rare Disease Perspective
Advocates, Patient Organizations, Students & Volunteers, Legislative Advocacy, Rare Disease Advisory Councils (RDAC), PDF, Policy, Toolkit: Advocating for a Rare Disease Advisory Council in Your State
Medical Professionals, Understanding Rare Disease, PDF, Education, Huntington’s Disease: Emerging Concepts in Diagnosis and Treatment
Medical Professionals, Patient Organizations, Researchers, RDCA-DAP, Research & Drug Development, PDF, Research, Accelerating Drug Development for Rare Diseases
Advocates, Patient Organizations, Students & Volunteers, Advocacy, Legislative Advocacy, RDCA-DAP, PDF, Policy, RDCA: What is it and What are its Core Components?
Advocates, Medical Professionals, Researchers, Advocacy, RDCA-DAP, Research & Drug Development, Infographic, PDF, Research, RDCA-DAP® Icongraphic
Advocates, Medical Professionals, Patient & Caregiver, Patient Organizations, Students & Volunteers, Advocacy, Legislative Advocacy, RDCA-DAP, Research & Drug Development, Infographic, PDF, Education, 5 Steps to Drug Development Brochure
